Complicated Urinary Tract Infection Treatment Global Market Report 2025

Description

Complicated urinary tract infection (UTI) treatment refers to the management of urinary tract infections in individuals with underlying conditions that increase the risk of treatment failure. This treatment involves using targeted antibiotics and supportive therapies to address infections caused by resistant pathogens or other complications. It is particularly used for severe UTIs in patients with structural abnormalities, immunocompromised conditions, or catheter use, ensuring effective infection control and preventing further complications.

The main drug types for complicated urinary tract infection treatment include penicillin and combinations, quinolones, cephalosporins, azoles and amphotericin B, and nitrofurans. Penicillin and combinations consist of antibiotics derived from penicillin, often combined with beta-lactamase inhibitors to enhance their effectiveness against resistant bacteria. These treatments are distributed through various channels, such as hospital pharmacies, gynecology and urology clinics, and drug stores. They are used for a range of conditions, including urethritis, cystitis, and pyelonephritis.

The complicated urinary tract infection treatment market research report is one of a series of new reports from The Business Research Company that provides complicated urinary tract infection treatment market statistics, including the complicated urinary tract infection treatment industry global market size, regional shares, competitors with the complicated urinary tract infection treatment market share, detailed complicated urinary tract infection treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the complicated urinary tract infection treatment industry. This complicated urinary tract infection treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The complicated urinary tract infection treatment market size has grown strongly in recent years. It will grow from $8.87 billion in 2024 to $9.47 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth during the historical period can be attributed to factors such as the increasing prevalence of urinary tract infections, a rise in cases of antibiotic resistance, a growing geriatric population, higher hospitalization rates, and greater awareness about UTIs.

The complicated urinary tract infection treatment market size is expected to see strong growth in the next few years. It will grow to $12.13 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth during the forecast period can be attributed to factors such as the growing prevalence of multidrug-resistant pathogens, an increasing focus on precision medicine, rising healthcare expenditure, greater use of rapid diagnostic testing, government initiatives, and funding for research. Key trends during this period include advancements in diagnostic techniques, expanding healthcare access in emerging markets, the development of novel antibiotics, technological innovations in diagnostic tools, and the adoption of combination therapies.

The increasing prevalence of chronic kidney disease (CKD) is expected to drive growth in the complicated urinary tract infection treatment market. CKD is a long-term condition marked by the gradual decline in kidney function over time. The rise in CKD cases is largely due to the growing rates of diabetes, hypertension, aging populations, and lifestyle factors such as obesity and smoking. Treatment for complicated urinary tract infections is crucial for CKD patients as it helps prevent severe infections such as pyelonephritis, which can worsen kidney damage, impair renal function, and accelerate the progression of CKD. This treatment reduces the risk of further complications and hospitalizations. For example, in December 2024, the Australian Institute of Health and Welfare reported that CKD was responsible for approximately 21,800 deaths in Australia in 2022. Moreover, in May 2024, Kidney Care UK stated that chronic kidney disease causes 40,000 to 45,000 premature deaths each year in the UK. Thus, the rising incidence of CKD is driving the growth of the complicated urinary tract infection treatment market.

Key companies in the complicated urinary tract infection treatment market are focusing on addressing antibiotic resistance through the development of novel antibiotics to improve treatment effectiveness and tackle emerging multidrug-resistant pathogens. Anti-infective therapies for complicated urinary tract infections involve using targeted antibiotics or antimicrobial agents to control infections, particularly in severe cases where the kidneys are affected. For instance, in February 2024, Allecra Therapeutics, a Germany-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved EXBLIFEP (cefepime/enmetazobactam) for treating complicated urinary tract infections in adults. The company also secured a five-year marketing exclusivity extension under the GAIN Act, which encourages the development of new anti-infective therapies. Clinical studies showed that 79.1% of patients treated with cefepime/enmetazobactam achieved a composite response (clinical cure and microbiological eradication), compared to 58.9% in those treated with piperacillin/tazobactam.

In June 2024, Orchid Pharma Limited, an India-based pharmaceutical company, partnered with Cipla Limited to launch cefepime/enmetazobactam in India. This collaboration aims to leverage Cipla's distribution network to enhance the availability of cefepime/enmetazobactam, an antibiotic used to treat complicated urinary tract infections, including pyelonephritis. Cipla, a prominent India-based pharmaceutical company, focuses on providing advanced antibiotics and innovative healthcare solutions for treating complicated urinary tract infections.

Major players in the complicated urinary tract infection treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., AstraZeneca PLC, Fresenius Kabi AG, GlaxoSmithKline plc, bioMerieux SA, Shionogi & Co. Ltd., Cipla Limited, Santen Pharmaceutical Co. Ltd., Orchid Pharma Limited, Melinta Therapeutics Inc., Spero Therapeutics Inc., Nabriva Therapeutics AG, Venatorx Pharmaceuticals Inc., Recce Pharmaceuticals Ltd, MerLion Pharmaceuticals Pte. Ltd., Entasis Therapeutics Holdings Inc., Allecra Therapeutics GmbH, Allergan Inc.

North America was the largest region in the complicated urinary tract infection treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in complicated urinary tract infection report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the complicated urinary tract infection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The complicated urinary tract infection treatment market consists of sales of antibiotics, antifungals, and combination therapy. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Complicated Urinary Tract Infection Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on complicated urinary tract infection treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for complicated urinary tract infection treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The complicated urinary tract infection treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Penicillin And combinations; Quinolones; Cephalosporin; Azoles And Amphotericin B; Nitro furans
2) By Distribution Channel: Hospital Pharmacies; Gynecology And Urology Clinics; Drug stores
3) By Application: Urethritis; Cystitis; Pyelonephritis
Subsegments:
1) By Penicillin And Combinations: Aminopenicillins; Beta-Lactamase Inhibitor Combinations
2) By Quinolones: Fluoroquinolones; Non-Fluoroquinolones
3) By Cephalosporin: First-Generation Cephalosporins; Second-Generation Cephalosporins; Third-Generation Cephalosporins; Fourth-Generation Cephalosporins; Fifth-Generation Cephalosporins
4) By Azoles And Amphotericin B: Triazoles; Imidazoles; Polyene Antifungals
5) By Nitrofurans: Nitrofurantoin; Furazolidone
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; AstraZeneca PLC; Fresenius Kabi AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r34022

1. Executive Summary

2. Complicated Urinary Tract Infection Treatment Market Characteristics

3. Complicated Urinary Tract Infection Treatment Market Trends And Strategies

4. Complicated Urinary Tract Infection Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Complicated Urinary Tract Infection Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Complicated Urinary Tract Infection Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Complicated Urinary Tract Infection Treatment Market Growth Rate Analysis
5.4. Global Complicated Urinary Tract Infection Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Complicated Urinary Tract Infection Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Complicated Urinary Tract Infection Treatment Total Addressable Market (TAM)

6. Complicated Urinary Tract Infection Treatment Market Segmentation

6.1. Global Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Penicillin And combinations
Quinolones
Cephalosporin
Azoles And Amphotericin B
Nitro furans
6.2. Global Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Gynecology and Urology Clinics
Drug stores
Retail Pharmacies
6.3. Global Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Urethritis
Cystitis
Pyelonephritis
6.4. Global Complicated Urinary Tract Infection Treatment Market, Sub-Segmentation Of Penicillin And Combinations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Aminopenicillins
Beta-Lactamase Inhibitor Combinations
6.5. Global Complicated Urinary Tract Infection Treatment Market, Sub-Segmentation Of Quinolones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluoroquinolones
Non-Fluoroquinolones
6.6. Global Complicated Urinary Tract Infection Treatment Market, Sub-Segmentation Of Cephalosporin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First-Generation Cephalosporins
Second-Generation Cephalosporins
Third-Generation Cephalosporins
Fourth-Generation Cephalosporins
Fifth-Generation Cephalosporins
6.7. Global Complicated Urinary Tract Infection Treatment Market, Sub-Segmentation Of Azoles And Amphotericin B, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Triazoles
Imidazoles
Polyene Antifungals
6.8. Global Complicated Urinary Tract Infection Treatment Market, Sub-Segmentation Of Nitrofurans, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nitrofurantoin
Furazolidone

7. Complicated Urinary Tract Infection Treatment Market Regional And Country Analysis

7.1. Global Complicated Urinary Tract Infection Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Complicated Urinary Tract Infection Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Complicated Urinary Tract Infection Treatment Market

8.1. Asia-Pacific Complicated Urinary Tract Infection Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Complicated Urinary Tract Infection Treatment Market

9.1. China Complicated Urinary Tract Infection Treatment Market Overview
9.2. China Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Complicated Urinary Tract Infection Treatment Market

10.1. India Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Complicated Urinary Tract Infection Treatment Market

11.1. Japan Complicated Urinary Tract Infection Treatment Market Overview
11.2. Japan Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Complicated Urinary Tract Infection Treatment Market

12.1. Australia Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Complicated Urinary Tract Infection Treatment Market

13.1. Indonesia Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Complicated Urinary Tract Infection Treatment Market

14.1. South Korea Complicated Urinary Tract Infection Treatment Market Overview
14.2. South Korea Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Complicated Urinary Tract Infection Treatment Market

15.1. Western Europe Complicated Urinary Tract Infection Treatment Market Overview
15.2. Western Europe Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Complicated Urinary Tract Infection Treatment Market

16.1. UK Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Complicated Urinary Tract Infection Treatment Market

17.1. Germany Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Complicated Urinary Tract Infection Treatment Market

18.1. France Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Complicated Urinary Tract Infection Treatment Market

19.1. Italy Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Complicated Urinary Tract Infection Treatment Market

20.1. Spain Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Complicated Urinary Tract Infection Treatment Market

21.1. Eastern Europe Complicated Urinary Tract Infection Treatment Market Overview
21.2. Eastern Europe Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Complicated Urinary Tract Infection Treatment Market

22.1. Russia Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Complicated Urinary Tract Infection Treatment Market

23.1. North America Complicated Urinary Tract Infection Treatment Market Overview
23.2. North America Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Complicated Urinary Tract Infection Treatment Market

24.1. USA Complicated Urinary Tract Infection Treatment Market Overview
24.2. USA Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Complicated Urinary Tract Infection Treatment Market

25.1. Canada Complicated Urinary Tract Infection Treatment Market Overview
25.2. Canada Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Complicated Urinary Tract Infection Treatment Market

26.1. South America Complicated Urinary Tract Infection Treatment Market Overview
26.2. South America Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Complicated Urinary Tract Infection Treatment Market

27.1. Brazil Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Complicated Urinary Tract Infection Treatment Market

28.1. Middle East Complicated Urinary Tract Infection Treatment Market Overview
28.2. Middle East Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Complicated Urinary Tract Infection Treatment Market

29.1. Africa Complicated Urinary Tract Infection Treatment Market Overview
29.2. Africa Complicated Urinary Tract Infection Treatment Market, Segmentation By Drug class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Complicated Urinary Tract Infection Treatment Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Complicated Urinary Tract Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Complicated Urinary Tract Infection Treatment Market Competitive Landscape And Company Profiles

30.1. Complicated Urinary Tract Infection Treatment Market Competitive Landscape
30.2. Complicated Urinary Tract Infection Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

31. Complicated Urinary Tract Infection Treatment Market Other Major And Innovative Companies

31.1. GlaxoSmithKline plc
31.2. bioMerieux SA
31.3. Shionogi & Co. Ltd.
31.4. Cipla Limited
31.5. Santen Pharmaceutical Co. Ltd.
31.6. Orchid Pharma Limited
31.7. Melinta Therapeutics Inc.
31.8. Spero Therapeutics Inc.
31.9. Nabriva Therapeutics AG
31.10. Venatorx Pharmaceuticals Inc.
31.11. Recce Pharmaceuticals Ltd
31.12. MerLion Pharmaceuticals Pte. Ltd.
31.13. Entasis Therapeutics Holdings Inc.
31.14. Allecra Therapeutics GmbH
31.15. Allergan Inc.

32. Global Complicated Urinary Tract Infection Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Complicated Urinary Tract Infection Treatment Market

34. Recent Developments In The Complicated Urinary Tract Infection Treatment Market

35. Complicated Urinary Tract Infection Treatment Market High Potential Countries, Segments and Strategies

35.1 Complicated Urinary Tract Infection Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Complicated Urinary Tract Infection Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Complicated Urinary Tract Infection Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer